Quick Answer
BIO-PATH HOLDINGS, INC. reported Earnings Per Share Diluted of $4.12 (loss) per share for the year ending 2024.
- BIO-PATH HOLDINGS, INC. showed an increase of +87.7% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from BIO-PATH HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $0.43 (loss) per share | Q2 2021: $0.26 (loss) per share | Q3 2021: $0.29 (loss) per share | Q1 2022: $0.47 (loss) per share | Q2 2022: $0.42 (loss) per share | Q3 2022: $0.49 (loss) per share | Q1 2023: $13.25 (loss) per share | Q2 2023: $10.64 (loss) per share | Q3 2023: $6.36 (loss) per share | Q1 2024: $4.88 (loss) per share | Q2 2024: $1.16 (loss) per share | Q3 2024: $0.70 (loss) per share | Q1 2025: $0.40 (loss) per share | Q2 2025: $0.55 (loss) per share | Q3 2025: $0.11 (loss) per share.
- Over the full 5 years of available data (2020 to 2024), BIO-PATH HOLDINGS, INC.'s Earnings Per Share Diluted has declined by 45.6%.
- Historical annual values: Fiscal year 2024: $4.12 (loss) per share | Fiscal year 2023: $33.63 (loss) per share | Fiscal year 2022: $38.12 (loss) per share | Fiscal year 2021: $1.55 (loss) per share | Fiscal year 2020: $2.83 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: